BOLD Reports $107.6M Cash, $58.2M Net Loss, Launches KOMODO-1 Trial, Halts POTENTIATE Study
Boundless Bio, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.44
+26% since the alert
$1.14 → $1.44
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS